Abstract

Research Article

Prognostic implications of vitamin D deficiency in chronic kidney disease

D Martínez-López, D Jover-Ríos, P Esteve-Atiénzar, J Méndez-Mora, A Méndez-Jover, F Caparrós-Hernández, V Jordá-Climent, C Seguí-Pérez, M Seguí-Pérez, C García-Cervera, JM Núñez-Cruz, J Guzmán-Martínez, I Hernández-Isasi, D Bonet-Tur, S Bañón-Escandell, J Peris-García, P Roig-Rico, A Pérez-Fullana and JM Seguí-Ripoll*

Published: 07 August, 2019 | Volume 3 - Issue 2 | Pages: 148-153

Chronic kidney disease (CKD) is a highly prevalent disease, imposing high mortality rates worldwide, and it is closely related to cardiovascular events. Vitamin D deficiency is very prevalent in patients with CKD from the earliest stages of the disease, and it has been associated with higher mortality. In order to assess the prognostic implications of vitamin D deficiency in CKD, we undertook a literature review, searching different databases in October 2018 for publications related to vitamin D in patients with CKD and hypovitaminosis D, and not on dialysis. The main cause of death in these patients is cardiovascular disease. Vitamin D is one of the first parameters that CKD changes and has an important prognostic role in this entity. Deficient levels in blood are associated with increased cardiovascular risk and survival impacts, independently of cardiovascular disease. Treatment with paricalcitol appears to reduce this risk. However, the evidence analyzed is insufficient to establish an association between vitamin D levels and the progression of kidney disease. 

Read Full Article HTML DOI: 10.29328/journal.jcn.1001040 Cite this Article Read Full Article PDF

Keywords:

Vitamin D deficiency; Chronic kidney disease; Mortality; Cardiovascular disease; Prognosis

References

  1. Webster AC, Nagler EV, Morton RL, Masson P. Chronic Kidney Disease. Lancet. 2017; 389(10075): 1238-1252. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/27887750
  2. Otero A, de Francisco A, Gayoso P, García F; EPIRCE Study Group. Prevalence of chronic renal disease in Spain: results of the EPIRCE study. Nefrologia. 2010; 30: 78-86. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/20038967
  3. Holick M. Vitamin D Deficiency. New England Journal of Medicine. 2007; 357: 266-281. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17634462
  4. Liu W, Wu C, Hung Y, Liao M, Shyu J, Lin Y et al. Pleiotropic effects of vitamin D in chronic kidney disease. Clinica Chimica Acta. 2016; 453: 1-12. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/26656443
  5. Obi Y, Hamano T, Isaka Y. Prevalence and prognostic implications of vitamin D deficiency in chronic kidney disease. Dis Markers. 2015; 2015: 868961. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/25883412
  6. Bess Dawson-Hughes. 2018 Vitamin D deficiency in adults: Definition, clinical manifestations, and treatment. UpToDate [Internet]. 2019. http:///www-uptodate.com
  7. Holick M. High Prevalence of Vitamin D Inadequacy and Implications for Health. Mayo Clinic Proc. 2006; 81: 353-373. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/16529140
  8. Mithal A, Wahl D, Bonjour J, Burckhardt P, Dawson-Hughes B, et al. Global vitamin D status and determinants of hypovitaminosis D. Osteoporosis International. 2009; 20: 1807-1820. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/19543765
  9. Jordi B, Jesús E, Elvira FG. Vitamina D, receptor de la vitamina D e importancia de su activación en el paciente con enfermedad renal crónica. Nefrología. 2015: 35: 1-12.
  10. Dusso A, González E, Martin K. Vitamin D in chronic kidney disease. Best Practice & Research Clinical Endocrinology & Metabolism. 2011; 25: 647-655. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21872805
  11. Yuste C, García De Vinuesa S, Goicoechea M. Deficiencia de vitamina D en una cohorte española de pacientes con enfermedad renal crónica. Medicina Clínica. 2013; 141: 338-342.
  12. Levin A, Bakris GL, Molitch M, Smulders M, Tian J, et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int. 2007; 71: 31-38. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/17091124
  13. Qunibi WY, Henrich WL. Overview of chronic kidney disease-mineral and bone disorder (CKD-MBD). [online] Uptodate.com 2019. http:///www-uptodate.com
  14. Currie G, Delles C. Proteinuria and its relation to cardiovascular disease. Int J Nephrol Renovasc Dis. 2013; 7: 13-24. PubMed:
  15. Shardlow A, McIntyre NJ, Fluck RJ, McIntyre CW, Taal MW, et al . Associations of fibroblast growth factor 23, vitamin D and parathyroid hormone with 5-year outcomes in a prospective primary care cohort of people with chronic kidney disease stage 3. BMJ Open. 2017; 7: e016528. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28838895
  16. Neyra JA, Hu MC. Potential application of klotho in human chronic kidney disease. Bone. 2017; 100: 41-49. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28115282
  17. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004; 351:1296–1305. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/15385656
  18. Keith DS, Nichols GA, Gullion CM, Brown JB, Smith DH. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med. 2004; 164: 659–663. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/15037495
  19. Thadhani R, Appelbaum E, Pritchett Y, Chang Y, Wenger J, et al. Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial. JAMA. 2012; 307: 674-684. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22337679
  20. García-Canton C, Bosch E, Ramírez A, Gonzalez Y, Auyanet I, et al. Vascular calcification and 25-hydroxyvitamin D levels in non-dialysis patients with chronic kidney disease stages 4 and 5. Nephrol Dial Transplant. 2011; 26: 2250-2256. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/20956810
  21. Chitalia N, Recio-Mayoral A, Kaski JC, Banerjee D. Vitamin D deficiency and endothelial dysfunction in non-dialysis chronic kidney disease patients. Atherosclerosis. 2012; 220: 265-268. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22071357
  22. Barreto DV, Barreto FC, Liabeuf S, Temmar M, Boitte F, et al. Vitamin D affects survival independently of vascular calcification in chronic kidney disease. Clin J Am Soc Nephrol. 2009; 4: 1128-1135. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/19443628
  23. Mehrotra R. Hypovitaminosis D and Progression of CKD. Chronic Kidney Disease in Disadvantaged Populations. 2017: 251-262.
  24. Mehrotra R, Kermah DA, Salusky IB, Wolf MS, Thadhani RI, et al. Chronic kidney disease, hypovitaminosis D, and mortality in the United States. Kidney Int. 2009; 76: 977-983. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/19657329
  25. Ravani P, Malberti F, Tripepi G, Pecchini P, Cutrupi S, et al. Vitamin D levels and patient outcome in chronic kidney disease. Kidney Int. 2009; 75: 88-95. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/18843258
  26. Pilz S, Iodice S, Zittermann A, Grant WB, Gandini S. Vitamin D status and mortality risk in CKD: a meta-analysis of prospective studies. Am J Kidney Dis. 2011; 58: 374-382. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21636193
  27. Navaneethan SD, Schold JD, Arrigain S, Jolly SE, Jain A, et al. Low 25-hydroxyvitamin D levels and mortality in non-dialysis-dependent CKD. Am J Kidney Dis. 2011; 58: 536-543. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/21816525
  28. Mariani LH, White MT, Shults J, Anderson CA, Feldman HI, et al. Increasing Use of Vitamin D Supplementation in the Chronic Renal Insufficiency Cohort Study. J Ren Nutr. 2014; 24: 186–193. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/24613295
  29. Duranton F, Rodriguez-Ortiz M, Duny Y, Rodriguez M, Daurès J, et al. Vitamin D Treatment and Mortality in Chronic Kidney Disease: A Systematic Review and Meta-Analysis. Am J Nephrol. 2013; 37: 239-248. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/23467111
  30. Mann MC, Hobbs AJ, Hemmelgarn BR, Roberts DJ, Ahmed SB, et al. Effect of oral vitamin D analogs on mortality and cardiovascular outcomes among adults with chronic kidney disease: a meta-analysis. Clin Kidney J. 2014; 8: 41-48. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/25713709
  31. Hu X, Shang J, Yuan W, Zhang S, Jiang Y, et al. Effects of paricalcitol on cardiovascular outcomes and renal function in patients with chronic kidney disease: A meta-analysis. Herz. 2018; 43: 518-528. PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28835982

Figures:

Figure 1

Figure 1

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?